Sukhinder Atkar-Khattra
Overview
Explore the profile of Sukhinder Atkar-Khattra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1008
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Warkentin M, Al-Sawaihey H, Lam S, Liu G, Diergaarde B, Yuan J, et al.
Thorax
. 2024 Jan;
79(4):307-315.
PMID: 38195644
Background: Low-dose CT screening can reduce lung cancer-related mortality. However, most screen-detected pulmonary abnormalities do not develop into cancer and it often remains challenging to identify malignant nodules, particularly among...
2.
Lam S, Wynes M, Connolly C, Ashizawa K, Atkar-Khattra S, Belani C, et al.
J Thorac Oncol
. 2023 Aug;
19(1):94-105.
PMID: 37595684
Introduction: With global adoption of computed tomography (CT) lung cancer screening, there is increasing interest to use artificial intelligence (AI) deep learning methods to improve the clinical management process. To...
3.
Khodayari Moez E, Warkentin M, Brhane Y, Lam S, Field J, Liu G, et al.
J Natl Cancer Inst
. 2023 Jun;
115(9):1060-1070.
PMID: 37369027
Background: Although lung cancer screening with low-dose computed tomography is rolling out in many areas of the world, differentiating indeterminate pulmonary nodules remains a major challenge. We conducted one of...
4.
Myers R, Ruszkiewicz D, Meister A, Bartolomeu C, Atkar-Khattra S, Thomas C, et al.
EBioMedicine
. 2023 Apr;
92:104584.
PMID: 37121096
Background: From a public health perspective, the identification of individuals with mild respiratory symptoms due to SARS-CoV-2 infection is important to contain the spread of the disease. The objective of...
5.
Cressman S, Weber M, Ngo P, Wade S, Behar Harpaz S, Caruana M, et al.
Lung Cancer
. 2023 Jan;
176:38-45.
PMID: 36592498
Objectives: Using risk models as eligibility criteria for lung screening can reduce race and sex-based disparities. We used data from the International Lung Screening Trial(ILST; NCT02871856) to compare the economic...
6.
Elisia I, Yeung M, Kowalski S, Wong J, Rafiei H, Dyer R, et al.
Front Nutr
. 2022 Dec;
9:1051418.
PMID: 36532545
Objectives: Given the current controversy concerning the efficacy of omega 3 supplements at reducing inflammation, we evaluated the safety and efficacy of omega 3 on reducing inflammation in people with...
7.
Tammemagi M, Ruparel M, Tremblay A, Myers R, Mayo J, Yee J, et al.
Lancet Oncol
. 2021 Dec;
23(1):138-148.
PMID: 34902336
Background: Lung cancer is a major health problem. CT lung screening can reduce lung cancer mortality through early diagnosis by at least 20%. Screening high-risk individuals is most effective. Retrospective...
8.
Myers R, Brauer M, Dummer T, Atkar-Khattra S, Yee J, Melosky B, et al.
J Thorac Oncol
. 2021 Jul;
16(11):1850-1858.
PMID: 34256112
Introduction: Air pollution may play an important role in the development of lung cancer in people who have never smoked, especially among East Asian women. The aim of this study...
9.
Byrne D, English J, Atkar-Khattra S, Lam S, Yee J, Myers R, et al.
J Thorac Imaging
. 2021 May;
36(6):373-381.
PMID: 34029281
Purpose: Primary lung cancers associated with cystic airspaces are increasingly being recognized; however, there is a paucity of data on their natural history. We aimed to evaluate the prevalence, pathologic,...
10.
Turner J, Pond G, Tremblay A, Johnston M, Goss G, Nicholas G, et al.
Chest
. 2021 Mar;
160(2):718-730.
PMID: 33667493
Background: A successful lung cancer screening program requires a patient cohort at sufficient risk of developing cancer who are willing to participate. Among other factors, a patient's lung cancer risk...